What is RSV Protection for Babies?
RSV (respiratory syncytial virus) is a leading cause of serious chest infections in babies. WHO recommends protecting infants either with a single vaccine dose for the mother late in pregnancy, or with a long-acting antibody given to the baby at birth.
Dosage and schedule
Mother: one dose in the third trimester, from about 28 weeks of pregnancy. Or baby: one dose of a long-acting antibody (such as nirsevimab) at birth.
Who it's for
- Pregnant women in the third trimester
- Newborns and babies in their first months
Benefits
- Protects babies in their first months against severe RSV chest infections.
- WHO recommends that all countries introduce RSV protection for infants.
Diseases prevented
- Severe RSV disease in infants (bronchiolitis and pneumonia)
Common reactions
- Mother: pain at the injection site, headache or muscle aches.
- Baby (antibody): occasional redness or swelling at the injection site.
Precautions
- Your doctor will advise which option suits you and your baby.
- Tell the doctor about any severe allergy to a previous dose.
When to seek help
- Seek care straight away if a baby has fast or difficult breathing, stops feeding, or turns pale or blue.
